Huzhou Central Hospital | China
Dr. Han Shuwen is an accomplished attending physician at Huzhou Central Hospital, specializing in oncology. He earned his Doctorate in Oncology from Zhejiang University and pursued postdoctoral studies at Ruijin Hospital, Shanghai Jiaotong University School of Medicine. With a profound dedication to medical advancements, he serves as the Vice President of the ASIR (Institute – Association of Intelligent Systems and Robotics) and holds key leadership roles in various interdisciplinary laboratories focused on colorectal cancer research.
Professional profile👤
ORCID
Scopus
Strengths for the Awards✨
✨ Han Shuwen’s research contributions in oncology, particularly colorectal cancer, are remarkable. His focus on intestinal microecology for clinical translational research has led to over 80 SCI-indexed publications, demonstrating a consistent output of high-quality research. Leading more than 50 projects, including those funded by the National Nature Foundation and the Ministry of Education, showcases his ability to manage large-scale, interdisciplinary studies. Additionally, his 13 patents and two published books reflect his drive for innovation and knowledge dissemination. His H-index of 22 highlights his research’s impact and citation frequency in the scientific community.
🎓 Education:
Han Shuwen’s academic journey is marked by his pursuit of excellence in medical sciences. He obtained his Doctor of Oncology degree from Zhejiang University and further enriched his expertise through postdoctoral training at Ruijin Hospital, Shanghai Jiaotong University School of Medicine. His educational background has laid a robust foundation for his pioneering research in colorectal cancer.
💼 Experience:
With a wealth of clinical and research experience, Han Shuwen holds the position of attending physician at Huzhou Central Hospital. Additionally, he plays a pivotal role as Vice President of ASIR, contributing significantly to the integration of intelligent systems and robotics in medicine. He also serves as the Deputy Director of the Zhejiang-France United Laboratory of Integrated Traditional Chinese and Modern Medicine in Colorectal Cancer and the Key Laboratory of Multiomics Research and Clinical Transformation of Digestive Cancer of Huzhou.
Han Shuwen’s research focuses on the intersection of clinical medicine and oncology, with a particular emphasis on colorectal cancer and intestinal microecology. His work delves into understanding cancer pathogenesis and developing translational clinical applications to improve patient outcomes.
🏆 Awards:
Han Shuwen’s outstanding contributions to oncology and medical research have earned him recognition in the scientific community. His pioneering work has been acknowledged through multiple awards and honors, reflecting his commitment to advancing medical knowledge and practice.
📖 Publications:
-
Escherichia coli on colorectal cancer: A two‐edged sword
-
Authors: Chu Jian, Wu Yinhang, Zhuang Jing, Qu Zhanbo, Wang Zefeng, Han Shuwen
-
Year: 2024
-
Gut microbial subtypes and clinicopathological value for colorectal cancer
-
Authors: Shuwen Han, Jing Zhuang, Yifei Song, Xinyue Wu, Xiaojian Yu, Ye Tao, Jian Chu, Zhanbo Qu, Yinhang Wu, Shugao Han et al.
-
Year: 2024
-
Third-generation PacBio sequencing to explore gut bacteria and gender in colorectal cancer
-
Authors: Sheng Yu, Jian Chu, Yinhang Wu, Jing Zhuang, Zhanbo Qu, Yifei Song, Xinyue Wu, Shuwen Han
-
Year: 2024
-
Trace elements in pancreatic cancer
-
Authors: Yao Yanjun, Zhuang Jing, Song Yifei, Gu Gangzhao, Yan Chenxin, Wei Qiang, Yan Qiang, Han Shuwen
-
Year: 2024
-
Bacterial imaging in tumour diagnosis
-
Authors: Jian Chu, Xiang Yu, Gaofei Jiang, Ye Tao, Wei Wu, Shuwen Han
-
Year: 2024
-
CFViSA: A comprehensive and free platform for visualization and statistics in omics-data
-
Authors: Ningqi Wang, Yarong Li, Shuwen Han, Yaozhong Zhang, Jun Yang, Zheng Yin, Cong Deng, Zijing Liu, Yinhang Wu, Wei Wu et al.
-
Year: 2024
-
Transcriptional profile and immune infiltration in colorectal cancer reveal the significance of inducible T‐cell costimulator as a crucial immune checkpoint molecule
-
Authors: Jian Chu, Yinghang Wu, Zhanbo Qu, Jing Zhuang, Jiang Liu, Shugao Han, Wei Wu, Shuwen Han
-
Year: 2024
-
Advances in bacteria‐based drug delivery systems for anti‐tumor therapy
-
Authors: Han Shuwen, Song Yifei, Wu Xinyue, Qu Zhanbo, Yu Xiang, Yang Xi
-
Year: 2024
-
The different prognostic factors between metastatic and nonmetastatic disease of esophageal neuroendocrine carcinoma
-
Authors: Liping Zhong, Yuefen Pan, Shuwen Han, Quan Qi, Haihong Liao, Yizhen Jiang, Junjun Shen
-
Year: 2023
-
Application and progress of high-content imaging in molecular biology
-
Authors: Hu Boyang, Wang Yangyanqiu, Rui Wenting, Yan Chenxin, Chu Jian, Qu Zhanbo, Yao Yanjun, Yan Qiang, Han Shuwen
-
Year: 2023
-
Aging characteristics of colorectal cancer based on gut microbiota
-
Authors: Yinhang Wu, Jing Zhuang, Qi Zhang, Xingming Zhao, Gong Chen, Shugao Han, Boyang Hu, Wei Wu, Shuwen Han
-
Year: 2023
📊 Conclusion:
Han Shuwen stands at the forefront of colorectal cancer research, merging clinical practice with innovative scientific inquiry. His relentless pursuit of knowledge has propelled significant advancements in oncology, with a strong focus on intestinal microecology. As a dedicated physician and researcher, his contributions continue to shape the landscape of cancer treatment and research, making him a deserving candidate for the Best Researcher Award.
